SNTI
Income statement / Annual
Last year (2024), Senti Biosciences, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2024, Senti Biosciences, Inc.'s net income was -$52.79 M.
See Senti Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$1.98 M |
$3.29 M |
$2.29 M |
$394.00 K |
$85.00 K |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$14.52 M
|
| Gross Profit |
$0.00
|
$1.98 M
|
$3.29 M
|
$2.29 M
|
$394.00 K
|
-$14.44 M
|
| Gross Profit Ratio |
0
|
1
|
1
|
1
|
1
|
-169.87
|
| Research and Development Expenses |
$34.36 M
|
$32.15 M
|
$28.15 M
|
$21.96 M
|
$15.96 M
|
$14.52 M
|
| General & Administrative Expenses |
$23.51 M
|
$34.87 M
|
$37.63 M
|
$21.25 M
|
$9.30 M
|
$7.34 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$23.51 M
|
$34.87 M
|
$37.63 M
|
$21.25 M
|
$9.30 M
|
$7.34 M
|
| Other Expenses |
$3.17 M
|
$27.69 M
|
-$408.00 K
|
-$470.00 K
|
-$172.00 K
|
$0.00
|
| Operating Expenses |
$61.04 M
|
$94.71 M
|
$65.37 M
|
$42.74 M
|
$25.09 M
|
$7.39 M
|
| Cost And Expenses |
$61.04 M
|
$94.71 M
|
$65.37 M
|
$42.74 M
|
$25.09 M
|
$21.92 M
|
| Interest Income |
$0.00
|
$2.86 M
|
$1.70 M
|
$11.00 K
|
$88.00 K
|
$674.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$5.85 M
|
$5.43 M
|
$3.92 M
|
$3.01 M
|
$1.99 M
|
$427.00 K
|
| EBITDA |
-$54.88 M |
-$61.34 M |
-$58.16 M |
-$37.44 M |
-$22.71 M |
-$21.36 M |
| EBITDA Ratio |
0
|
-31.01
|
-17.7
|
-16.34
|
-57.64
|
-251.24
|
| Operating Income Ratio |
0
|
-46.88
|
-18.89
|
-17.65
|
-62.68
|
-256.26
|
| Total Other Income/Expenses Net |
$8.25 M
|
$9.32 M
|
$12.42 M
|
-$14.87 M
|
$4.83 M
|
$625.00 K
|
| Income Before Tax |
-$52.79 M
|
-$83.41 M
|
-$49.67 M
|
-$55.32 M
|
-$19.86 M
|
-$21.16 M
|
| Income Before Tax Ratio |
0
|
-42.17
|
-15.11
|
-24.15
|
-50.41
|
-248.91
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$52.79 M
|
-$71.06 M
|
-$58.21 M
|
-$55.32 M
|
-$19.86 M
|
-$21.16 M
|
| Net Income Ratio |
0
|
-35.92
|
-17.71
|
-24.15
|
-50.41
|
-248.91
|
| EPS |
-11.49 |
-20.94 |
-13.25 |
-12.67 |
-4.55 |
-15.57 |
| EPS Diluted |
-11.49 |
-20.94 |
-13.25 |
-12.67 |
-4.55 |
-15.57 |
| Weighted Average Shares Out |
$4.60 M
|
$4.44 M
|
$4.39 M
|
$4.37 M
|
$4.37 M
|
$1.36 M
|
| Weighted Average Shares Out Diluted |
$4.60 M
|
$4.44 M
|
$4.39 M
|
$4.37 M
|
$4.37 M
|
$1.36 M
|
| Link |
|
|
|
|
|
|
